Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1022-1023, 2003; 10.1373/49.6.1022
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arndt, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arndt, T.
Related Collections
Right arrow Drug Monitoring and Toxicology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:1022-1023.)
© 2003 American Association for Clinical Chemistry, Inc.


Letters to the Editor

Asialotransferrin—An Alternative to Carbohydrate-deficient Transferrin?

Torsten Arndt

Bioscientia GmbH, Konrad-Adenauer-Strasse 17, D-55218 Ingelheim, Germany, Fax 49-6132-781-428, E-mail arndt@bioscientia.de

The first 20% of the full text of this article appears below.


To the Editor:

Asialotransferrin, monosialotransferrin, and disialotransferrin are collectively referred to as carbohydrate-deficient transferrin (CDT) (1)(2). Over the last several years, the definition of CDT has become increasingly vague (which transferrin isoforms are CDT isoforms and which are not). Thus, different transferrin isoforms are analyzed with various recoveries as CDT (2). The lack of standardization of CDT analysis complicates the preanalysis, analysis, and interpretation of CDT. To overcome this problem, consistent use of the CDT definition introduced by Stibler (1), a redefinition of CDT, or replacement by a clearly defined analyte is needed (2).

In our laboratory, using isoelectric focusing for transferrin isoform analysis (3)(4)(5), we observed a high prevalence of bands for asialotransferrin and monosialotransferrin, plus an increased fraction of disialotransferrin, in serum samples with increased CDT. In contrast, samples from healthy persons (with typical alcohol intake and CDT values within the reference interval) usually did not show asialo- and monosialotransferrin bands. Similar observations have been reported by others (1)(2). This prompted the suggestion to replace the analyte group CDT by asialotransferrin as a clearly defined analyte (6). However, there has not been a sufficiently sensitive and quantitative analytical method available to investigate the value of asialotransferrin as a marker of . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
J.-B. Daeppen, F. Anex, B. Favrat, A. Bissery, J. Leutwyler, R. Gammeter, P. Mangin, and M. Augsburger
Carbohydrate-Deficient Transferrin Measured by Capillary Zone Electrophoresis and by Turbidimetric Immunoassay for Identification of Young Heavy Drinkers
Clin. Chem., June 1, 2005; 51(6): 1046 - 1048.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Schwan, L. Malet, M.N. Loiseaux, and P.M. Llorca
Which Types of Alcohol-Use Disorder Will Asialotransferrin Detect?
Clin. Chem., April 1, 2004; 50(4): 782 - 782.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Helander, A. Husa, and J.-O. Jeppsson
Improved HPLC Method for Carbohydrate-deficient Transferrin in Serum
Clin. Chem., November 1, 2003; 49(11): 1881 - 1890.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.